financetom
Business
financetom
/
Business
/
Sberbank CEO puzzled by Russia's push to create digital rouble
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sberbank CEO puzzled by Russia's push to create digital rouble
Jul 2, 2025 9:58 AM

ST PETERSBURG, Russia, July 2 (Reuters) - German Gref,

CEO of Russia's dominant lender Sberbank, on Wednesday

said he did not see any potential benefits to Russia's

development of the digital rouble beyond the possible exception

of cross-border settlements.

Russian banks will be required to offer customers the means

to make payments using digital roubles from September 1, 2026,

the central bank said last week, pushing the project's planned

launch back by over a year.

More than 130 countries are exploring digital versions of

their currencies, according to the Atlantic Council, as the

world's financial authorities respond to declining cash usage

and the threat to their money-printing powers from the likes of

bitcoin.

Moscow hopes the digital rouble will simplify foreign trade

payments that have been complicated by Western sanctions over

the conflict in Ukraine.

"I don't see its advantages," Gref told reporters during a

financial forum in St Petersburg. "As an individual, I don't

understand why digital roubles are needed. As a bank... I don't

yet understand it very well either."

Russian banks already have strong digital finance

capacities, such as cashless settlements, Gref said, reiterating

that he saw no possibility for the digital rouble to

meaningfully transform Russia's economy.

No digital currency has become dominant within any country,

he said, but there could be a future in cross-border

settlements.

"Domestically, I don't see it yet," he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Micron Technology to Levy Surcharge on Data Storage Products in Response to Tariffs
Market Chatter: Micron Technology to Levy Surcharge on Data Storage Products in Response to Tariffs
Apr 8, 2025
02:22 PM EDT, 04/08/2025 (MT Newswires) -- Micron Technology ( MU ) will levy a surcharge on several of its products starting April 9 in response to new US tariffs, Reuters reported Tuesday, citing sources close to the matter. The sources said Micron informed customers in a letter that the tariffs apply to memory modules and solid-state drives, and these...
Update: Barclays Downsizing DEI Efforts for US Operations
Update: Barclays Downsizing DEI Efforts for US Operations
Apr 8, 2025
02:16 PM EDT, 04/08/2025 (MT Newswires) -- (Updates with company remarks, other details throughout.) Barclays ( JJCTF ) is scaling back its staffing diversity goals in the US while continuing those efforts in other countries, the company said on Tuesday. A Barclays ( JJCTF ) spokesperson told MT Newswires via email that while the UK-based financial services company is no...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
Apr 8, 2025
Argenx SE ( ARGX ) showcased long-term data of Vyvgart (IV: efgartigimod alfa-fcab and SC or Hytrulo: efgartigimod alfa and hyaluronidase-qvfc) demonstrating sustained disease control of generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP) with a favorable safety profile. ADAPT-NXT Part B data demonstrated clinically meaningful improvements as early as Week 1 with Vyvgart’s bi-weekly and every three-week...
Copyright 2023-2026 - www.financetom.com All Rights Reserved